Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy

Heart

Volumn 96, Issue 5, 2010, Pages 357-361

  Unno, Kazumasa ^a   Shibata, Rei ^a   Izawa, Hideo ^a   Hirashiki, Akihiro ^a   Murase, Yosuke ^a   Yamada, Takashi ^a   Kobayashi, Masakazu ^a   Noda, Akiko ^b   Nagata, Kohzo ^b   Ouchi, Noriyuki ^c   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2;

ADULT; AGED; AORTA ROOT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS; DIASTOLE; DIASTOLIC DYSFUNCTION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE PRESSURE; HEART LEFT VENTRICLE PRESSURE HALF TIME; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PERIPHERAL VEIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TURNOVER TIME;

ADIPONECTIN; AORTA, THORACIC; BIOLOGICAL MARKERS; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY SINUS; DIASTOLE; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; STROKE VOLUME; VEINS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77649226769     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.172320     Document Type: Article

References (30)

1. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-20.
2. Ashrafian H, Redwood C, Blair E, et al. Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion. Trends Genet 2003;19:263-8.
3. Tuunanen H, Kuusisto J, Toikka J, et al. Myocardial perfusion, oxidative metabolism, and free fatty acid uptake in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene: a positron emission tomography study. J Nucl Cardiol 2007;14:354-65.
4. Ouchi N, Kihara S, Funahashi T, et al. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14:561-6.
5. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med 2006;16:141-6.
6. Lopaschuk GD, Folmes CD, Stanley WC. Cardiac energy metabolism in obesity. Circ Res 2007;101:335-47.
7. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 2002;8:731-7.
8. Hong SJ, Park CG, Seo HS, et al. Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index. Blood Press 2004;13:236-42.
9. Ebinc H, Ebinc FA, Ozkurt ZN, et al. Impact of adiponectin on left ventricular mass index in non-complicated obese subjects. Endocr J 2008;55:523-8.
10. Mitsuhashi H, Yatsuya H, Tamakoshi K, et al. Adiponectin level and left ventricular hypertrophy in Japanese men. Hypertension 2007;49:1448-54.
11. Kozakova M, Muscelli E, Flyvbjerg A, et al. Adiponectin and left ventricular structure and function in healthy adults. J Clin Endocrinol Metab 2008;93:2811-8.
12. Shibata R, Ouchi N, Ito M, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 2004;10:1384-9.
13. Shibata R, Izumiya Y, Sato K, et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 2007;42:1065-74.
14. Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005;112:1756-62.
15. George J, Patal S, Wexler D, et al. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 2006;92:1420-4.
16. Ingelsson E, Riserus U, Berne C, et al. Adiponectin and risk of congestive heart failure. JAMA 2006;295:1772-4.
17. Wigle ED, Rakowski H, Kimball BP, et al. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 1995;92:1680-92.
18. Somura F, Izawa H, Iwase M, et al. Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase mRNA expression and biphasic force-frequency relations in patients with hypertrophic cardiomyopathy. Circulation 2001;104:658-63.
19. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
20. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-9.
21. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459-69.
22. Furuhashi M, Ura N, Moniwa N, et al. Possible impairment of transcardiac utilization of adiponectin in patients with type 2 diabetes. Diabetes Care 2004;27:2217-21.
23. Takahashi T, Saegusa S, Sumino H, et al. Adiponectin, T-cadherin and tumour necrosis factor-alpha in damaged cardiomyocytes from autopsy specimens. J Int Med Res 2005;33:236-44.
24. Ishikawa Y, Akasaka Y, Ishii T, et al. Changes in the distribution pattern of gelatin-binding protein of 28 kDa (adiponectin) in myocardial remodelling after ischaemic injury. Histopathology 2003;42:43-52.
25. Shibata R, Sato K, Kumada M, et al. Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment. Cardiovasc Res 2007;74:471-9.
26. Yamauchi T, Kamon J, Ito Y, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003;423:762-9.
27. Fujioka D, Kawabata KI, Saito Y, et al. Role of adiponectin receptors in endothelin-induced cellular hypertrophy in cultured cardiomyocytes and their expression in infarcted heart. Am J Physiol Heart Circ Physiol 2006;290:H2409-16.
28. Saito Y, Fujioka D, Kawabata K, et al. Statin reverses reduction of adiponectin receptor expression in infarcted heart and in TNF-alpha-treated cardiomyocytes in association with improved glucose uptake. Am J Physiol Heart Circ Physiol 2007;293:H3490-7.
29. Lin HV, Kim JY, Pocai A, et al. Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice. Diabetes 2007;56:1969-76.
30. Mullen KL, Pritchard J, Ritchie I, et al. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high fat fed rats. Am J Physiol Regul Integr Comp Physiol 2009;296:R243-51.